These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8658673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS, Shaheen FA, Mathew MC, Abou Zeinab HM, Al Alfi A, Tarif NM, Al Mousawi MS, Mahmoud TS, Alorrayed AS, Fagir EA, Dham RS, Shaker DS.
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C, Melchor JL, Miranda ME, Bartolano C.
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract] [Full Text] [Related]

  • 5. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H, Asmundsson P, Clausen P, Dieperink H, Hansen JM, Heaf J, Jensen SB, Kornerup HJ, Madsen S, Pedersen EB, Poulsen JV, Rasmussen K.
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract] [Full Text] [Related]

  • 6. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
    Halimi JM, Giraudeau B, Buchler M, Al-Najjar A, Etienne I, Laouad I, Bruyère F, Lebranchu Y.
    Clin Transplant; 2007 Aug; 21(2):277-84. PubMed ID: 17425758
    [Abstract] [Full Text] [Related]

  • 7. Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation.
    Shin GT, Cheigh JS, Riggio RR, Suthanthiran M, Stubenbord WT, Serur D, Wang JC, Rubin A, Stenzel KH.
    Transplant Proc; 1996 Jun; 28(3):1309-10. PubMed ID: 8658672
    [No Abstract] [Full Text] [Related]

  • 8. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC, Koomans HA.
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [Abstract] [Full Text] [Related]

  • 9. No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem.
    Aros CA, Ardiles LG, Schneider HO, Flores CA, Alruiz PA, Jerez VR, Mezzano SA.
    Transplant Proc; 2005 Oct; 37(8):3364-6. PubMed ID: 16298597
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of kidney functions and cyclosporine levels in renal transplant patients on Panimum Bioral in post transplant period.
    Sharma DR, Singh S.
    J Indian Med Assoc; 1999 May; 97(5):204-5. PubMed ID: 10652891
    [Abstract] [Full Text] [Related]

  • 11. Felodipine in hypertensive heart transplant recipients.
    Ambrosi P, Bertucci B, Bertault-Péres P, Métras D.
    J Heart Lung Transplant; 1996 May; 15(5):540-1. PubMed ID: 8771512
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Case reports on conversion to Neoral therapy in renal transplant patients.
    Curtis JJ.
    Transplant Proc; 1996 Aug; 28(4):2221-2; discussion 2218. PubMed ID: 8769205
    [No Abstract] [Full Text] [Related]

  • 14. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME, Beer JC, Raftery MJ, Dawnay A, Barton C, Marsh FP.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract] [Full Text] [Related]

  • 15. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B, Korn A.
    Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract] [Full Text] [Related]

  • 18. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
    Gonzalez Molina M, Morales JM, Marcen R, Campistol JM, Oppenheimer F, Serón D, Gil-Vernet S, Capdevila L, Andrés A, Lampreave I, Del Castillo D, Cabello M, Burgos D, Valdés F, Anaya F, Escuín F, Arias M, Pallardó L, Bustamante J.
    Transplant Proc; 2007 Sep; 39(7):2167-9. PubMed ID: 17889126
    [Abstract] [Full Text] [Related]

  • 19. C2 monitoring of cyclosporine in stable renal transplant patients results in lower costs and improved renal function.
    Domínguez J, Fuenzalida D, Norambuena R, Pais E, Cortes Monroy G, Llanos R.
    Transplant Proc; 2005 Apr; 37(3):1583-5. PubMed ID: 15866680
    [Abstract] [Full Text] [Related]

  • 20. Effects of low-dose ketoconazole on thyroid hormones in renal transplant recipients.
    García R, Henríquez-La Roche C, Rubio L, Herrera J, Salgado O, Rodríguez-Iturbe B.
    Transplant Proc; 1996 Dec; 28(6):3368-9. PubMed ID: 8962311
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.